Investigational Gene Therapy Slows Huntington’s Disease Progression

By News Health
4 hours Ago

(MedPage Today) — Topline data showed that an investigational gene therapy slowed Huntington’s disease progression and met its primary endpoint in a pivotal trial, uniQure Biopharma announced Wednesday.
A high-dose version of the treatment, known…

Source link : https://www.medpagetoday.com/neurology/generalneurology/117633

Author :

Publish date : 2025-09-24 21:19:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

The lives on hold waiting for wheelchairs

Trends in Global Cancer Cases, Deaths Offer Little Reassurance

Skipping First Breast Cancer Screening Has Long-Term Consequences

Insecticide-Treated Baby Wraps Ward Off Malaria

Huntington’s disease breakthrough: what to know about the gene therapy

Does FDA's Leucovorin Decision Meet the Bar for Gold-Standard Science?